This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout
References
Gardam MA et al. (2003) Anti-tumour necrosis factor agents and tuberculosis risk: mechanisms of action and clinical management. Lancet Infect Dis 3: 148–155
Arend SM et al. (2003) TNF-alpha blockade and tuberculosis: better look before you leap. Neth J Med 61: 111–119
Dinarello CA (2005) Differences between anti-tumor necrosis factor-alpha monoclonal antibodies and soluble TNF receptors in host defense impairment. J Rheumatol (Suppl) 74: 40–47
Menzies D (1999) Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med 159: 15–21
Ravn P et al. (2004) Reactivation of tuberculosis during immunosuppressive treatment in a patient with a positive QuantiFERON-RD1 test. Scand J Infect Dis 36: 499–501
Acknowledgements
The synopsis was written by Jasmine Farsarakis, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Huizinga, T., Arend, S. Is the tuberculin skin test an accurate method of detecting tuberculosis in patients with rheumatoid arthritis?. Nat Rev Rheumatol 2, 188–189 (2006). https://doi.org/10.1038/ncprheum0161
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1038/ncprheum0161